Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Endo International plc

https://www.endo.com/

Latest From Endo International plc

Endo Brings All Xiaflex Revenue In House With BioSpecifics Acquisition

Deal snapshot: Resolving a loose end from its 2014 buyout of Auxilium, Endo acquires all rights to Xiaflex, along with approved cellulite therapy Qwo.

Deals M & A

Finance Watch: Kronos Bio IPO Raises $250m To Fund Novel Cancer Drugs

Initial public offerings by Norbert Bischofberger’s start-up as well as Spruce Biosciences and Shattuck Labs bring the US total to 65 in 2020. Also, the pipeline of health care SPACs is growing, Everest and Genor went public in Hong Kong, Idorsia leads recent follow-on offerings and Corbus cuts jobs.

Financing Growth

OxyContin Abuse-Deterrent Postmarketing Data Are In. Now What?

Purdue’s postmarketing studies leave many unanswered questions about reformulated OxyContin, including the ‘million-dollar’ question of its impact on addiction. Advisory committee members ask for clarity on what constitutes ‘meaningful reduction’ in abuse and advise FDA on what to tell the public about the data.

Advisory Committees Post Market Regulation & Studies

How Much Should Governments Pay For COVID-19 Monoclonal Antibody Therapies?

US government’s $450m manufacturing commitment for Regeneron’s antibody cocktail and Gilead’s price for remdesivir drive lower expectations on pricing for the antibody treatments, especially since it seems likely there could be several competing products.

Coronavirus COVID-19 Pricing Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • American Medical Systems, Inc.
    • Anchen Pharmaceuticals, Inc.
    • ASTORA Women's Health
    • Auxilium Pharmaceuticals, Inc. (Actient Pharmaceuticals LLC
    • Slate Pharmaceuticals)
    • DAVA Pharmaceuticals, Inc
    • Edict Pharmaceuticals Private Limited
    • Endo Finance LLC
    • Endo Health Solutions Inc.
    • Endo Pharmaceuticals Holdings Inc.
    • Endo Ventures Limited
    • HealthTronics, Inc.
    • Indevus Pharmaceuticals, Inc.
    • JHP Pharmaceuticals, LLC
    • Paladin Labs Inc. (Allon Therapeutics, Inc.
    • Ativa Pharma S.A,
    • Labopharm Inc.
    • Triton Pharma, Inc.
    • ViRexx Medical Corp.)
    • Par Pharmaceutical Companies, Inc.
    • Par Pharmaceutical, Inc.
    • Penwest Pharmaceuticals Co.
    • Qualitest Pharmaceuticals
    • Strativa Pharmaceuticals
    • Valera Pharmaceuticals
UsernamePublicRestriction

Register